BioCardia has announced positive results from a Phase I/II trial of its Helical Infusion system, designed to deliver donor's (allogeneic) or treated patient's (autologous) adult mesenchymal stem cells (MSCs) via transendocardial stem cell ...
Tags: Helical Infusion system, stem cell injection, device, Infusion System
Cytori Therapeutics, a developer of cell therapies based on autologous adipose-derived regenerative cells (ADRCs), has obtained Russian approval for its Celution 800 system. The Celution system and its related products including ADRCs ...
Tags: cell therapy, Celution 800 system, clinical product, clinical research
Superior skin care – luxurious creams with anti-aging effect While you sleep, the active indredients of the night cream fulfill their mission so that in the morning you wake up bright and smiling. The selection of facial care ...
Tags: Night Creams, Skincare Products, Creams
Cytori Therapeutics has expanded its Celution system's CE mark approval to include several new indications including cryptoglandular fistula. The Celution system, which pulls stem cells and other regenerative cells out of fat , provides ...
Tags: Cytori Therapeutics, cryptoglandular fistula, celution system
Pluristem Therapeutics, a developer of placenta-based cell therapies, is seeking FDA orphan drug status for its PLacental eXpanded (PLX) cells for the treatment of aplastic anemia. Pluristem earlier received an orphan drug status from the ...
RS Medical is set to distribute Harvest Technologies' Terumo SmartPReP 2 platelet concentrate system, as part of a recently completed agreement. Harvest, a Terumo Americas Holding company, is involved in developing point-of-care ...
Tags: clinical technology, cellular platform, company cooperation
bluebird bio has received $9.3m Strategic Partnership Award from California Institute for Regenerative Medicine (CIRM) to support phase 1/2 studies of LentiGlobin to treat beta-thalassemia. bluebird bio chief medical officer David ...
Tags: bluebird bio, LentiGlobin, CIRM
Medistem and Superview Biotechnology, a subsidiary of Yinhuan Holding Co from Yixing, collaborate for the development of therapeutics using antibody and stem cell technology. The collaboration will leverage proprietary stem cell lines ...
Tags: therapeutics, antibody and stem cell technology, regenerative medicine
Cellectis stem cells, a business unit of Cellectis Group, has introduced hiPS-HEP, a human iPS derived hepatocyte product. The hiPS-HEP, with homogeneity, a long life span of stable CYP activity and reproducibility, provides a range of in ...
Tags: hiPS-HEP, iPS derived hepatocyte product, vitro applications
Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells. Developed in collaboration with pharma and biotechnology companies, the Cellaxess platform enables scalable ...
Tags: Cellectricon, Cellaxess elektra discovery platform, adherent cells
The US Patent and Trademark Office (USPTO) has granted patent No. 8,232,262 to Ziopharm Oncology's palifosfamide (ZIO-201). The patent covers palifosfamide compositions, formulations, methods of use and methods of manufacture, which now ...
Tags: USPTO, patent, Palifosfamide, cancer treatment drug
The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation system. The Magellan system utilizes ...
Tags: FDA, Anticoagulant Citrate Dextrose Solution, clinical technology